Silence Therapeutics (SLN) Return on Assets [ROA] (2022 - 2026)
Silence Therapeutics (SLN) posted Return on Assets [ROA] of -54.13% for the quarter ended Jun 30, 2026, down 8.98 percentage points from -45.15% a year earlier but up 6.74 percentage points from the prior quarter.
Powered by 
Analysis
Silence Therapeutics (SLN) Return on Assets [ROA] (2022 - 2026) Analysis & Trends
For the year ended Dec 31, 2025, Silence Therapeutics' Return on Assets [ROA] came in at -53.05%, down 24.91 percentage points from the prior year.
- In prior years, Silence Therapeutics' Return on Assets [ROA] was -28.13% in the year ended Dec 31, 2024.
- Quarterly Return on Assets [ROA] has run from a low of -63.70% in the quarter ended Dec 31, 2025 to a high of -36.88% in the quarter ended Mar 31, 2025 over five years.
- According to Business Quant data, Return on Assets [ROA] for the three prior quarters was -60.87% (quarter ended Mar 31, 2026), -63.70% (quarter ended Dec 31, 2025) and -41.37% (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 19.00% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 8.08% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 7.32% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 1.87% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 9.36% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 9.80% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -7.67% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 2.00% |
| 10 | Silence Therapeutics | 935.01 Mn | 862.91 Mn | - | -54.13% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -54.13% |
| Mar 31, 2026 | -60.87% |
| Dec 31, 2025 | -63.70% |
| Sep 30, 2025 | -41.37% |
| Jun 30, 2025 | -44.89% |
| Mar 31, 2025 | -36.59% |
| Dec 31, 2024 | -8.68% |
| Sep 30, 2024 | -9.68% |
| Jun 30, 2024 | -7.52% |
| Mar 31, 2024 | -11.83% |
| Dec 31, 2023 | -17.23% |
| Sep 30, 2023 | -10.36% |
| Jun 30, 2023 | -9.78% |
| Mar 31, 2023 | -10.17% |
| Dec 31, 2022 | -18.52% |
| Sep 30, 2022 | -286.88% |
API Access
Silence Therapeutics Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=SLN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "SLN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=SLN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();